Logo image
Caged Garcinia Xanthones, a Novel Chemical Scaffold with Potent Antimalarial Activity
Journal article   Open access   Peer reviewed

Caged Garcinia Xanthones, a Novel Chemical Scaffold with Potent Antimalarial Activity

Hangjun Ke, Joanne M Morrisey, Shiwei Qu, Oraphin Chantarasriwong, Michael W Mather, Emmanuel A Theodorakis and Akhil B Vaidya
Antimicrobial agents and chemotherapy, v 61(1)
27 Dec 2016
PMID: 27799215
url
https://doi.org/10.1128/aac.01220-16View
Published, Version of Record (VoR)Open Access (License Unspecified) Open
url
https://doi.org/10.1128/AAC.01220-16View
Published, Version of Record (VoR) Open

Abstract

Antimalarials Experimental Therapeutics Garcinia Xanthones
Caged Garcinia xanthones (CGXs) constitute a family of natural products that are produced by tropical/subtropical trees of the genus Garcinia. CGXs have a unique chemical architecture, defined by the presence of a caged scaffold at the C ring of a xanthone moiety, and exhibit a broad range of biological activities. Here we show that synthetic CGXs exhibit antimalarial activity against Plasmodium falciparum, the causative parasite of human malaria, at the intraerythrocytic stages. Their activity can be substantially improved by attaching a triphenylphosphonium group at the A ring of the caged xanthone. Specifically, CR135 and CR142 were found to be highly effective antimalarial inhibitors, with 50% effective concentrations as low as ∼10 nM. CGXs affect malaria parasites at multiple intraerythrocytic stages, with mature stages (trophozoites and schizonts) being more vulnerable than immature rings. Within hours of CGX treatment, malaria parasites display distinct morphological changes, significant reduction of parasitemia (the percentage of infected red blood cells), and aberrant mitochondrial fragmentation. CGXs do not, however, target the mitochondrial electron transport chain, the target of the drug atovaquone and several preclinical candidates. CGXs are cytotoxic to human HEK293 cells at the low micromolar level, which results in a therapeutic window of around 150-fold for the lead compounds. In summary, we show that CGXs are potent antimalarial compounds with structures distinct from those of previously reported antimalarial inhibitors. Our results highlight the potential to further develop Garcinia natural product derivatives as novel antimalarial agents.

Metrics

14 Record Views
22 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Microbiology
Pharmacology & Pharmacy
Logo image